| abstract |
The invention relates to polysulfated glycosides of formula (I), (see formula I) wherein R1, R2, R3, R4, R5 and R6 independently of each other, stand for C1-4 alkyl, --SO3H, polysulfated glycosyl or polysulfated diglycosyl group - with the proviso that at least one of R1-R6 is a polysulfated glycosyl or polysulfated diglycosyl group - the pharmaceutically acceptable salts thereof, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furthermore the invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals - including asthma and asthma--related pathologies. |